Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.

[1]  L. Bullinger,et al.  Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients. , 2019, Blood.

[2]  D. Liang,et al.  Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells , 2018, Neoplasia.

[3]  M. Dubé,et al.  Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A. , 2018, Blood.

[4]  P. A. Futreal,et al.  Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Markus G. Manz,et al.  Molecular Minimal Residual Disease in Acute Myeloid Leukemia , 2018, The New England journal of medicine.

[6]  B. Dörken,et al.  Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis , 2018, Leukemia.

[7]  W. Hiddemann,et al.  Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia , 2017, Leukemia.

[8]  J. Passweg,et al.  Acute myeloid leukaemia genomics , 2017, British journal of haematology.

[9]  Mingming Jia,et al.  COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..

[10]  Christopher A. Miller,et al.  Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML. , 2016, Blood.

[11]  S-H Jung,et al.  Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression , 2016, Leukemia.

[12]  D. Grimwade,et al.  Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. , 2016, Blood.

[13]  Christopher A. Miller,et al.  Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. , 2015, JAMA.

[14]  Margaret A. Goodell,et al.  DNMT3A in haematological malignancies , 2015, Nature Reviews Cancer.

[15]  Lincoln D. Stein,et al.  Identification of pre-leukemic hematopoietic stem cells in acute leukemia , 2014, Nature.

[16]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[17]  T. Naoe,et al.  Gene mutations of acute myeloid leukemia in the genome era , 2013, International Journal of Hematology.

[18]  Yong-mei Zhu,et al.  Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia , 2011, Nature Genetics.

[19]  Augustin Ferrant,et al.  Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. , 2003, The New England journal of medicine.